Navigation Links
Centice Corporation Enhances the PASS Rx System with its Version 3.0 Software Update

Centice Corporation, a pioneer in drug verification and safety products, announced today that it has released a new version of its PASS Rx system.

Morrisville, NC (PRWEB) February 1, 2010 -- Centice Corporation, a pioneer in drug verification and safety products, announced today that it has released a new version of its PASS Rx system. PASS Rx scientifically verifies, within a closed pill vial, the majority of the oral solid medications to improve the dispense accuracy in pharmacies. PASS Rx is the most reliable solution to allow pharmacies to protect themselves and their patients.

According to a 2006 report from the Institute of Medicine, at least 1.5 million Americans are injured by medication errors every year, many due to the wrong drug or strength being dispensed. Another study states that about four drug or strength errors occur per day in a pharmacy with a daily volume of 250 prescriptions. Manual verification can be largely subjective; Centice can help.

The new enhancements in Version 3.0 include an increased database size to over two thousand unique medications, which equates to more than 20,000 NDCs. In addition, PASS Rx can now be used to perform accuracy scans for barcode-based verification of non-vial dispensed drugs. Combined, these enhancements enable PASS Rx to cover nearly 100% of the workflow in retail and hospital outpatient pharmacies.

After multiple customer focus groups were conducted, the new user interface was also improved to provide the pharmacist or technician with easy to understand results on the display. The user interface continues to provide Medi-Span® drug images and descriptions for the added value of visual verification.

Centice Corporation provides its customers with storage and reporting capabilities to enhance quality control in the pharmacy. Anything scanned and/or analyzed through the PASS Rx system is captured for future reporting on how many scripts were filled, how many were run through PASS Rx and how many errors have been caught.

Periodic updates are provided remotely so that Centice may provide its customers with the most up-to-date information as drugs are added or removed from the library and for faster customer service.

”We are thrilled to offer our pharmacy customers an improved solution that will assist them in increasing their quality and efficiency, ultimately allowing them to do what they do best, spend more time consulting with their patients,” said Scott Albert, Chairman of the Board and Chief Executive Officer of Centice.

About Centice Corporation
Centice, founded in 2004 and headquartered in Morrisville, NC, is commercializing patented and patent-pending computational sensor and machine vision technology. The PASS Rx® pharmaceutical authentication sensor system improves the verification process for dispensed medications, thereby improving quality and optimizing workflow in the pharmacy. The company has received venture capital investments from The Aurora Funds, Inc., Novak Biddle Venture Partners, S-Group Direct Investments Ltd, Innovation Ventures LP, Fulcrum Financial Group, L.P. and other private investors. More information on Centice can be found at

# # #

Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Providence Service Corporation to Present at the Jefferies 2010 Global Healthcare Services Conference on Monday, January 25th
2. Centage Corporation Reports 16% Growth in 2009; Planning Maestro, Business Performance Management Software Implementations on the Rise
3. Hepregen Corporation Receives SBIR Phase II Grant from the National Science Foundation and Presents Corporate Update at OneMed Forum
4. United American Healthcare Corporation Announces Meeting Date and Record Date for Annual Meeting of Shareholders
5. Amerigroup Corporation to Discuss Fourth Quarter and 2009 Year-End Earnings on February 19
6. Providence Service Corporation Comments on Senate Health Care Reform
7. Triple-S Management Corporation to Present at J. P. Morgan Healthcare Conference
8. Service Corporation International Extends Offer for Keystone North America Inc.
9. Atrion Networking Corporation Selects Ruckus Wireless for Reliable as Wire Enterprise Wi-Fi Service
10. Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees Benefit Selection Process
11. China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009
Post Your Comments:
Related Image:
Centice Corporation Enhances the PASS Rx System with its Version 3.0 Software Update  
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: